HERON THERAPEUTICS, INC. /DE/ (HRTX)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-08-02 and 2026-10-31, public records show 2 signals for HERON THERAPEUTICS, INC. /DE/. Most notable: 2026-08-14: Filed 8-K disclosing material agreement; 2026-09-29: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-10-31 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-10-19Collard Craig AdirectorF3,3600.36$1,210
2026-10-19Collard Craig AdirectorM13,797——
2026-10-19Forbes William PofficerF1,1020.36$397
2026-10-19Forbes William PofficerM3,874——
2026-10-19Duarte IraofficerF1,1020.36$397
2026-10-19Duarte IraofficerM3,874——
2026-06-16Duarte IraofficerF3,5550.38$1,351
2026-06-16Duarte IraofficerM12,500——
2026-06-06Forbes William PofficerM12,500——
2026-05-06Hensley Mark EarlofficerM125,000——
2026-04-30Hensley Mark EarlofficerM11,770——
2026-04-30Forbes William PofficerM11,770——
2026-04-30Forbes William PofficerM11,694——
2026-04-30Duarte IraofficerM11,694——
2026-04-30Duarte IraofficerM13,535——
2026-04-30Collard Craig AdirectorM34,789——
2026-04-30Collard Craig AdirectorM50,021——
2026-04-19Forbes William PofficerM3,874——
2026-04-19Collard Craig AdirectorM13,797——
2026-04-19Duarte IraofficerM3,874——
2026-04-03Collard Craig AdirectorM62,500——
2026-01-31Duarte IraofficerM11,695——
2026-01-31Forbes William PofficerM11,695——
2026-01-31Collard Craig AdirectorM34,789——
2026-01-30Christian WaagedirectorA53,9600$0
2026-01-30Kaseta MichaeldirectorA53,9600$0
2026-01-30Johnson Craig AdirectorA53,9600$0
2026-01-30Cusack ThomasdirectorA53,9600$0
2026-01-30Dissanaike SharmiladirectorA53,9600$0
2026-01-30Morgan AdamdirectorA53,9600$0
2026-01-19Forbes William PofficerM3,875——
2026-01-19Duarte IraofficerM3,875——
2026-01-19Collard Craig AdirectorM13,797——
2025-11-08Cusack ThomasdirectorA37,879——
2025-10-31Forbes William PofficerM11,694——
2025-10-31Duarte IraofficerM11,694——
2025-10-31Collard Craig AdirectorM34,789——
2025-10-19Forbes William PofficerM3,874——
2025-10-19Duarte IraofficerM3,874——
2025-10-19Collard Craig AdirectorM13,797——
2025-10-15Rosen David Efraimten percent ownerC946,100——
2025-08-08Rosen David Efraimten percent ownerP2,387,2251.5$3,580,838
2025-08-08Morgan AdamdirectorP1,766,5461.5$2,649,819
2025-07-31Forbes William PofficerM11,695——
2025-07-31Duarte IraofficerM11,695——
2025-07-31Collard Craig AdirectorM34,789——
2025-07-19Forbes William PofficerM3,874——
2025-07-19Duarte IraofficerM3,874——
2025-07-19Collard Craig AdirectorM13,797——
2025-06-16Duarte IraofficerM12,500——

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

  • 2026-10-27 S-8
  • 2026-10-21 4
  • 2026-10-21 4
  • 2026-10-21 4
  • 2026-09-29 8-K
  • 2026-08-14 8-K
  • 2026-08-10 4
  • 2026-08-10 10-Q
  • 2026-08-10 8-K
  • 2026-08-03 4
  • 2026-08-03 4
  • 2026-08-03 4
  • 2026-08-03 4
  • 2026-07-20 4
  • 2026-07-20 4
  • 2026-07-20 4
  • 2026-06-25 8-K
  • 2026-06-17 4
  • 2026-06-16 8-K
  • 2026-06-08 4